BORDEAUX, France & BOSTON--(BUSINESS WIRE)--Regulatory News:
IMPLANET (Paris:IMPL) (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants, announced today that management will participate at BIO CEO & Investor Conference 2016 to be held February 8-9, 2016 at the Waldorf Astoria New York.
IMPLANET (Paris:IMPL) (Euronext: IMPL, FR0010458729, PEA-PME eligible), a medical technology company specializing in vertebral and knee-surgery implants, announced today that management will participate at BIO CEO & Investor Conference 2016 to be held February 8-9, 2016 at the Waldorf Astoria New York.
